Story 1 source • Updated 1 day ago • top: bloomberg.com

Compass Pathways CEO on Trump's Order to Expand Psychedelics Research

This is a live story built from multiple sources. It may evolve quickly.
Coverage meter • 1 min window
B bloomberg.com
What’s included
Top recent items from this story.
1 items • 1 unique links
Bloomberg Markets 1 day ago • bloomberg.com
Compass Pathways CEO on Trump's Order to Expand Psychedelics Research
Shares of companies involved in psychedelic-tied therapies surged Monday after President Donald Trump signed an executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53%…
Open